This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
WP1 - Project Management, coordinated by ICFO
Financial and administrative management of the project, coordination of the consortium and planning of the schedule and timings.
WP2 - Deployment of VASCOVID modules, led by POLIMI
Deployment of the two sets of innovative modules to be incorporated into two cost-effective, fast, easy-to-deploy VASCOVID prototypes
WP3 - Validation and standardization, led by BioPixS
Accelerating the system prototyping process by defining and executing a set of standardization protocols for multi-level – components, modules, prototype – standardized testing of the system.
WP4 - VASCOVID prototyping, led by ICFO
Integration of the modules, developed throughout the WP2 and WP3, while ensuring regulatory readiness.
WP5 - Clinical validation, coordinated by Parc Taulí
Development of three clinical protocols to study the feasibility of the prototype in a healthy population and in both general ICU and COVID-19 patients.
WP6 - Communication & dissemination, coordinated by ICFO
Devise and implement the communication and dissemination plans, design the corporate image, branding, and materials, content creation, media and press synergies and relations, organization of related events.
WP7 - Exploitation, coordinated by HemoPhotonics
Develop a clear roadmap to accomplish certification, commercialization and large scale manufacturing within a short period of time, evaluating of possibly additional products, services and IP.
“This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101016087″
